- Home
- IGTA vs FBIO Comparison
IGTA vs FBIO Comparison
Compare IGTA & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGTA
- FBIO
- Stock Information
- Founded
- IGTA 2021
- FBIO 2006
- Country
- IGTA United States
- FBIO United States
- Employees
- IGTA N/A
- FBIO N/A
- Industry
- IGTA Blank Checks
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- IGTA Finance
- FBIO Health Care
- Exchange
- IGTA Nasdaq
- FBIO Nasdaq
- Market Cap
- IGTA 46.2M
- FBIO 39.4M
- IPO Year
- IGTA 2021
- FBIO N/A
- Fundamental
- Price
- IGTA $11.52
- FBIO $1.77
- Analyst Decision
- IGTA
- FBIO Strong Buy
- Analyst Count
- IGTA 0
- FBIO 3
- Target Price
- IGTA N/A
- FBIO $18.00
- AVG Volume (30 Days)
- IGTA 13.9K
- FBIO 699.0K
- Earning Date
- IGTA 01-01-0001
- FBIO 11-14-2024
- Dividend Yield
- IGTA N/A
- FBIO N/A
- EPS Growth
- IGTA 29.68
- FBIO N/A
- EPS
- IGTA 0.12
- FBIO N/A
- Revenue
- IGTA N/A
- FBIO $81,501,000.00
- Revenue This Year
- IGTA N/A
- FBIO N/A
- Revenue Next Year
- IGTA N/A
- FBIO $134.70
- P/E Ratio
- IGTA $99.46
- FBIO N/A
- Revenue Growth
- IGTA N/A
- FBIO 31.51
- 52 Week Low
- IGTA $10.64
- FBIO $1.36
- 52 Week High
- IGTA $12.49
- FBIO $4.43
- Technical
- Relative Strength Index (RSI)
- IGTA 32.79
- FBIO 43.63
- Support Level
- IGTA $11.65
- FBIO $1.41
- Resistance Level
- IGTA $11.75
- FBIO $2.27
- Average True Range (ATR)
- IGTA 0.10
- FBIO 0.18
- MACD
- IGTA -0.06
- FBIO -0.04
- Stochastic Oscillator
- IGTA 0.00
- FBIO 8.06
About IGTA Inception Growth Acquisition Limited
Inception Growth Acquisition Ltd is a blank check company.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.